Overview
What is New York Cardiothoracic Transplant Consortium Inc?
Established in 2011, the New York Cardiothoracic Transplant Consortium (NYCTC) is a non-profit organization that unites heart and lung transplant professionals from seven heart and three lung transplant programs in New York State. The primary purpose of NYCTC is to foster collaboration, share data, and engage in peer review, with the ultimate goal of improving the quality of heart and lung transplant services in the state. They achieve this by providing accurate and current information about transplantation to various stakeholders, developing and reviewing policies to optimally use the limited organ supply, and ensuring fair access to organs for patients, regardless of factors such as age, ethnicity, or financial status. Additionally, NYCTC collaborates with New York State Organ Procurement Organizations to ensure adherence to organ allocation policies.
Official website here: www.nycardiothoracic.org
Is New York Cardiothoracic Transplant Consortium Inc legitimate?
New York Cardiothoracic Transplant Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. New York Cardiothoracic Transplant Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $129,984
For more financial information, click here
Official website here: www.nycardiothoracic.org
What is the mission statement of New York Cardiothoracic Transplant Consortium Inc?
The New York Cardiothoracic Transplant Consortium Inc, established in 2011, is a non-profit organization that aims to improve heart and lung transplant services. It brings together professionals from seven heart and three lung transplant programs in New York State, encouraging collaboration, data sharing, and peer review. The consortium achieves this by providing accurate and updated information about heart and lung transplantation, developing and reviewing policies to optimally utilize the limited organ supply, and ensuring fair organ allocation regardless of various factors. Furthermore, they collaborate with New York State Organ Procurement Organizations to ensure compliance with organ allocation policies.
Official website here: www.nycardiothoracic.org
What is the revenue of New York Cardiothoracic Transplant Consortium Inc?
New York Cardiothoracic Transplant Consortium Inc's revenue in 2024 was $245,881.
Official website here: www.nycardiothoracic.org
Who are the executives of New York Cardiothoracic Transplant Consortium Inc and what are their salaries?
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.nycardiothoracic.org
Where can I find the form 990 for New York Cardiothoracic Transplant Consortium Inc?
New York Cardiothoracic Transplant Consortium Inc's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.nycardiothoracic.org
Learn more at the official website: www.nycardiothoracic.org
Mission Statement of New York Cardiothoracic Transplant Consortium Inc
New York Cardiothoracic Transplant Consortium Inc, a non-profit organization established in 2011, is dedicated to bringing together heart and lung transplant professionals. Their mission is centered around collaboration, data sharing, and peer review, all with the aim of enhancing the quality of heart and lung transplant services. This consortium is composed of seven heart transplant and three lung transplant programs in New York State.
The organization's primary goal is to provide accurate and current information about heart and lung transplantation to various stakeholders, including transplant professionals, recipients, donors, and their families. This information sharing is crucial in ensuring that all parties involved have the necessary knowledge to make informed decisions. Additionally, New York Cardiothoracic Transplant Consortium Inc works towards developing and reviewing policies to make the best use of the limited supply of organs. By doing so, they aim to give patients in New York State a fair chance at receiving the organ they need, regardless of factors such as age, sex, ethnicity, religion, lifestyle, or financial/social status.
Furthermore, the consortium collaborates with the New York State Organ Procurement Organizations to ensure that organ allocation policies are followed. This collaboration is essential in ensuring that the process of organ allocation is fair and equitable, and that every patient has an equal opportunity to receive a life-saving transplant. In summary, New York Cardiothoracic Transplant Consortium Inc is committed to improving heart and lung transplant services by promoting collaboration, data sharing, and policy development, ultimately benefiting patients and their families.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The New York Cardiothoracic Transplant Consortium (NYCTC) has made significant strides in improving the quality of heart and lung transplant services in New York State since its establishment in 2011. By unifying the efforts of seven heart and three lung transplant programs, the consortium fosters collaboration among transplant professionals, enhancing data sharing and peer review processes.
One of the consortium's key impacts is its commitment to providing accurate and up-to-date information about transplantation to various stakeholders, including transplant professionals, recipients, donors, and their families. This dissemination of knowledge helps ensure that everyone involved is well-informed about the procedures, risks, and outcomes related to heart and lung transplants.
Additionally, the NYCTC focuses on developing and reviewing policies that optimize the use of the limited supply of organs available for transplant. By promoting fair and equitable access to these vital resources, regardless of a patient's age, sex, ethnicity, religion, lifestyle, or financial status, the consortium aims to give all patients in New York State a fair opportunity to receive necessary transplants.
Moreover, the organization collaborates with New York State's organ procurement organizations to ensure that organ allocation policies are adhered to, which enhances the overall efficiency and effectiveness of the transplant process. Through these collaborative efforts, the NYCTC plays a crucial role in advancing transplant services and improving patient outcomes across the state.
This information is meant to be a general summary of New York Cardiothoracic Transplant Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $9,987
- Program Service Revenue: $130,000
- Gross Receipts: $245,881
Assets and Liabilities:
- Total Assets: $258,416
- Total Liabilities: $14,359
- Net Assets: $244,057
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
HOSPITAL DUES
Revenue
$130,000
Organization Details
Founding Year
2011
Principal Officer
Leway Chen Md
Website
www.nycardiothoracic.orgNTEE Category
Code: G43 - Disease
If you are a representative of New York Cardiothoracic Transplant Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.